ReviewEFORT open reviews2023
Microfasciectomy in Dupuytren's disease: microsurgery in the evolution toward safer and more efficient fasciectomy and hand surgery.
Review in EFORT open reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
- Microscopic Fasciectomy in Dupuytren Disease: Early Clinical Outcomes and Technical Advantages-A District General Hospital Experience.Journal of hand surgery global online · 2026Article
- Top 75 most-cited articles in hand microsurgery: A bibliometric and visualised analysis.Journal of hand and microsurgery · 2025Article
- Challenges and innovations in the surgical treatment of advanced Dupuytren disease by percutaneous needle fasciotomy: indications, limitations, and medico-legal implications.Journal of orthopaedic surgery and research · 2024Article
- WALANT surgery of the hand: state of the art.EFORT open reviews · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the long term, limited fasciectomy is currently the most reliable treatment for Dupuytren's contracture. The risk for complications is significant, certainly in recurrent disease and in the presence of abundant scar tissue. Meticulous surgical technique is mandatory. Microsurgery increases magnification from four times (with surgical loupes) up to 40 times. Using the microscope in Dupuytren's surgery, a technique named microfasciectomy is likely to increase both safety and efficiency by preventing instead of treating surgical complications. Increased experience with microsurgery will benefit Dupuytren's treatment and hand surgery in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.